Underrepresentation of female subjects in BE study to register Generic [Regulatives / Guidelines]

posted by ping4santosh  – India, 2020-03-11 16:15 (428 d 02:56 ago) – Posting: # 21254
Views: 3,652

Hi ElMaestro,

It's not a random flutter. Females actually fall back on bioequivalncy. Cmax at 75% and range was lower too. Pioneer product behaved similar way. So it's not random. You are right. The females also has higher variance.

I didn't understand your last statement. Can you kindly clarify?

» Yes, you can likely conduct the study in males. But why would you if you think the conclusion in males can be extrapolated



Complete thread:

 Admin contact
21,460 posts in 4,486 threads, 1,511 registered users;
online 3 (0 registered, 3 guests [including 3 identified bots]).
Forum time: Thursday 20:11 CEST (Europe/Vienna)

Nothing in the world is more dangerous
than sincere ignorance
and conscientious stupidity.    Martin Luther King, Jr.

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz